Safety procedures of coagulation factors-Reference-Cited by-同舟云学术

Safety procedures of coagulation factors

Published:2007-12-07 Issue: Volume:13 Page:41-46
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

JORQUERA J. I.

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2007.01578.x/fullpdf

Reference34 articles.

1. Inactivation of viruses in labile blood derivatives;Horowitz;Transfusion,1985

2. West Nile virus: recent experience with the model virus approach;Kreil;Dev Biol (Basel),2004

3. H5N1 influenza virus and the safety of plasma products;Kreil;Transfusion,2007

4. Robustness study of specific virus inactivation steps in the manufacturing process of a high purity factor VIII concentrate, FANHDI;Biescas;Haematologica,1999

5. Inactivation of parvovirus B19 during pasteurization of human serum albumin;Blümel;Transfusion,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines;Vaccine;2017-01

2. Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use;BLOOD TRANSFUS-ITALY;2016

3. Characterization of Markers of the Progression of Human Parvovirus B19 Infection in Virus DNA-Positive Plasma Samples;Transfusion Medicine and Hemotherapy;2015

4. “Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed!;Transfusion and Apheresis Science;2014-10

5. Robustness of nanofiltration for increasing the viral safety margin of biological products;Biologicals;2014-03